Neuroprotective Agent

CHICAGO — In this video, Joan W. Miller, MD, chair of ophthalmology at Mass Eye and Ear, discusses study results presented at the AAO meeting on ONL1204 from ONL Therapeutics.

In this video, Barbara Blodi, MD, discusses early data on neuroprotective agents for the treatment of geographic atrophy.

In this video, Arshad M. Khanani, MD, MA, FASRS, discusses the results of the phase 2 ARCHER trial of ANX007 from Annexon Biosciences in patients with geographic atrophy, presented at the American Academy of Ophthalmology meeting.